Yahoo · Sep 9, 2026
Cigna Group Executive Neville Everett Sells 617 Shares for $175,000
Everett disposed of 11% of his direct equity holdings under a pre-arranged Rule 10b5-1 trading plan, leaving a stake valued at $1.45 million.
NASDAQ · CI
Cigna Corporation
Healthcare · Medical - Healthcare Plans
$288.90
Down-$1.15 (-0.40%)
Updated Sep 16, 2026, 12:00 PM
SID Score
7.4/10
Composite research score
Smart Money
47/100
Neutral
- Market cap
- 72.73B
- P/E ratio
- 11.79
- Dividend yield
- 2.09%
- 52-week range
- $257.85 – $305.44
- Volume
- 1.26M
- Avg. volume
- 1.95M
Price performance
CI price history
1M range · 20 trading sessions · Daily adjusted prices
CI closed at $288.90 after 20 trading sessions, up 3.73% for the selected period.
- Last close
- $288.90
- Period change
- +3.73%
- Period low
- $274.41
- Period high
- $290.05
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $289.90 | $290.715 | $286.715 | $288.90 | 1.26M |
| Sep 14, 2026 | $284.60 | $290.94 | $284.60 | $290.05 | 1.31M |
| Sep 11, 2026 | $283.01 | $285.00 | $277.51 | $280.76 | 1.34M |
| Sep 10, 2026 | $280.56 | $285.50 | $278.94 | $280.91 | 1.55M |
| Sep 9, 2026 | $279.00 | $282.45 | $272.34 | $278.17 | 1.55M |
| Sep 8, 2026 | $279.10 | $279.37 | $275.26 | $275.83 | 1.59M |
| Sep 4, 2026 | $283.06 | $284.67 | $281.63 | $282.52 | 1.2M |
| Sep 3, 2026 | $284.05 | $286.53 | $280.95 | $286.26 | 1.67M |
| Sep 2, 2026 | $283.10 | $286.81 | $280.70 | $282.84 | 1.49M |
| Sep 1, 2026 | $279.66 | $283.555 | $278.71 | $283.06 | 1.3M |
| Aug 31, 2026 | $278.99 | $278.99 | $275.59 | $276.08 | 1.42M |
| Aug 28, 2026 | $280.68 | $280.68 | $277.65 | $278.88 | 1.6M |
| Aug 27, 2026 | $277.79 | $281.80 | $276.31 | $277.67 | 1.23M |
| Aug 26, 2026 | $279.70 | $286.01 | $279.40 | $280.87 | 1.23M |
| Aug 25, 2026 | $278.87 | $279.55 | $276.25 | $279.32 | 1.64M |
| Aug 24, 2026 | $278.51 | $281.73 | $276.96 | $280.45 | 1.97M |
| Aug 21, 2026 | $274.81 | $279.39 | $274.25 | $277.51 | 2.06M |
| Aug 20, 2026 | $277.24 | $278.80 | $274.04 | $274.41 | 1.09M |
| Aug 19, 2026 | $279.61 | $282.745 | $276.91 | $277.45 | 1.13M |
| Aug 18, 2026 | $278.50 | $282.58 | $277.73 | $278.50 | 920.79K |
Latest CI news
The latest Smart Investors Daily articles mentioning CI.
Stock researchCompany · Overview
CI research
Overview
Company profile and research snapshot.
Company profile
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $333.00
- Implied upside
- —
- Analysts
- 17
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Jefferies | Hold | — |
| Aug 3, 2026 | Raymond James | Outperform | — |
| Jul 31, 2026 | Barclays | Equal-Weight | — |
| Jul 31, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 31, 2026 | Guggenheim | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 9, 2026
The Cigna Group to Host Investor Day on September 30
Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 30, 2026.
SeekingAlpha · Sep 6, 2026
Wall Street Brunch: Make Or Break Inflation For The Fed
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Yahoo · Sep 6, 2026
The GLP-1 Squeeze: How Soaring Healthcare Costs Are Forcing Employers to Act
As employers brace for a fresh round of rising healthcare costs that outpace inflation, the stakes are getting higher for companies to contain spending on treatments such as popular GLP-1 medications for weight loss.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
